PrecisionLife licenses OXEGENE dataset to develop personalized treatments for endometriosis

FHS
July 10, 2023
6:01 am

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

U.K.’s cost-effectiveness agency says Alzheimer’s drug donanemab does not provide good value

LONDON — For the second time in a matter of months, the U.K.’s cost-effectiveness watchdog has said the limited benefits of a newly approved Alzheimer’s

October 23, 2024

Cantourage Group SE continues profitable growth course in first half of 2023 – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Half Year Results/Financing Cantourage Group SE continues profitable growth course in first half of 2023 20.07.2023 / 08:30

July 21, 2023

BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 – Biotech Investments

BioVersys AG / Key word(s): IPO BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW,

February 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.